Dysregulation of ZFAS1 has been reported in hepatocellular carcinoma (Li T. et al., 2015), breast cancer (Hansji et al., 2016) and many other types of human cancers (Xu et al., 2018; He et al., 2019). Here, ZFAS1 is linked to hepatocellular carcinoma.